AKAN
Price
$3.66
Change
-$0.37 (-9.18%)
Updated
Aug 29, 04:56 PM (EDT)
Capitalization
9.17M
HNSPF
Price
$4.58
Change
-$0.62 (-11.92%)
Updated
Aug 25 closing price
Capitalization
27.51B
Interact to see
Advertisement

AKAN vs HNSPF

Header iconAKAN vs HNSPF Comparison
Open Charts AKAN vs HNSPFBanner chart's image
Akanda
Price$3.66
Change-$0.37 (-9.18%)
Volume$299
Capitalization9.17M
Hansoh Pharmaceutical Group
Price$4.58
Change-$0.62 (-11.92%)
Volume$800
Capitalization27.51B
AKAN vs HNSPF Comparison Chart in %
Loading...
AKAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HNSPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKAN vs. HNSPF commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKAN is a Buy and HNSPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (AKAN: $4.03 vs. HNSPF: $4.58)
Brand notoriety: AKAN and HNSPF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AKAN: 140% vs. HNSPF: 83%
Market capitalization -- AKAN: $9.17M vs. HNSPF: $27.25B
AKAN [@Pharmaceuticals: Generic] is valued at $9.17M. HNSPF’s [@Pharmaceuticals: Generic] market capitalization is $27.25B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKAN’s FA Score shows that 0 FA rating(s) are green whileHNSPF’s FA Score has 1 green FA rating(s).

  • AKAN’s FA Score: 0 green, 5 red.
  • HNSPF’s FA Score: 1 green, 4 red.
According to our system of comparison, HNSPF is a better buy in the long-term than AKAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKAN’s TA Score shows that 6 TA indicator(s) are bullish while HNSPF’s TA Score has 4 bullish TA indicator(s).

  • AKAN’s TA Score: 6 bullish, 3 bearish.
  • HNSPF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, AKAN is a better buy in the short-term than HNSPF.

Price Growth

AKAN (@Pharmaceuticals: Generic) experienced а -1.56% price change this week, while HNSPF (@Pharmaceuticals: Generic) price change was -11.92% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.25%. For the same industry, the average monthly price growth was +68.20%, and the average quarterly price growth was +81.63%.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HNSPF($27.5B) has a higher market cap than AKAN($9.17M). HNSPF YTD gains are higher at: 114.701 vs. AKAN (-19.400).
AKANHNSPFAKAN / HNSPF
Capitalization9.17M27.5B0%
EBITDA-3.03MN/A-
Gain YTD-19.400114.701-17%
P/E RatioN/A40.96-
Revenue837KN/A-
Total Cash3.84MN/A-
Total Debt353KN/A-
TECHNICAL ANALYSIS
Technical Analysis
AKANHNSPF
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
50%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
63%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
60%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
25%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
46%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
18%
Advances
ODDS (%)
Bullish Trend 23 days ago
83%
Bullish Trend 11 days ago
90%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
50%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
AKAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HNSPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
MIR.X0.0209640.009301
+79.74%
Mirror Protocol cryptocurrency
AXL.X0.3190660.011894
+3.87%
Axelar cryptocurrency
MBOX.X0.0613590.001554
+2.60%
MOBOX cryptocurrency
POWR.X0.1672320.004136
+2.54%
Powerledger cryptocurrency
SUI.X3.4898930.054343
+1.58%
Sui cryptocurrency

AKAN and

Correlation & Price change

A.I.dvisor tells us that AKAN and SCYX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKAN and SCYX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKAN
1D Price
Change %
AKAN100%
+2.81%
SCYX - AKAN
32%
Poorly correlated
+1.76%
CRON - AKAN
26%
Poorly correlated
+1.56%
TLRY - AKAN
26%
Poorly correlated
+7.30%
EBS - AKAN
26%
Poorly correlated
-2.33%
ANIK - AKAN
25%
Poorly correlated
+0.54%
More

HNSPF and

Correlation & Price change

A.I.dvisor tells us that HNSPF and RMTI have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HNSPF and RMTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HNSPF
1D Price
Change %
HNSPF100%
N/A
RMTI - HNSPF
24%
Poorly correlated
+22.45%
AYURF - HNSPF
11%
Poorly correlated
N/A
AKAN - HNSPF
8%
Poorly correlated
+2.81%
IXHL - HNSPF
5%
Poorly correlated
-7.80%
BFRI - HNSPF
4%
Poorly correlated
-0.99%
More